[1] Li S, Sun W, Wang H, et al. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol. 2015;36(3): 1329-1338.
[2] Jiang F, Shi Y, Li GJ, et al. A meta-analysis of limb-salvage versus amputation in the treatment of patients with Enneking‡U pathologic fracture osteosarcoma. Indian J Cancer. 2015;51 Suppl 2:e21-24.
[3] Zheng S, Zhou S, Qiao G, et al. Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma. Am J Cancer Res. 2014;5(1):411-422.
[4] Sun M, Zhou C, Zeng H, et al. Hiporfin-Mediated Photodynamic Therapy in Preclinical Treatment of Osteosarcoma. Photochem Photobiol. 2015. in press.
[5] Tamamyan G, Dominkus M, Lang S, et al. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy? Pediatr Blood Cancer. 2015;62(3):529-530.
[6] Bacci G, Lari S. Current treatment of high grade osteosarcoma of the extremity: review. J Chemother. 2001; 13(3):235-243.
[7] Meier D, Campanile C, Botter SM, et al. Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro. J Vis Exp. 2014;(85).
[8] Sun L, Zhou DS, Zhang P, et al. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma. Int J Pharm. 2014;478(1):308-317.
[9] Salvage J, Thorpe J, Santin M. Soybean-based biomaterial granules induce biomineralization in MG-63 human osteosarcoma osteoblast-like cells through ultrastructural changes and phagocytic activity. J Mater Sci Mater Med. 2015;26(3):5451.
[10] Carlsson G, Gullberg B, Hafström L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol. 1983;105(1):20-23.
[11] Wang K, Wang C, Wu W, et al. Establishment of animal model of human cervical cancer in BALB/c nude mice by tumor tissue xenograft. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014;32(6):441-443.
[12] Li H, Li X, Gao X, et al. Induction of apoptosis by tumor necrosis factor receptors 2 transgene in human laryngeal squamous cacinoma in nude mice animal model. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23(3):125-129.
[13] Li LX, Tang YM, Gu WZ, et al. Establishment of animal model with B lineage acute leukemia in nude mice for evaluation of new therapeutic agents. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008;37(5):511-514.
[14] Yamamoto T, Nishioka K. Animal model of sclerotic skin. VI: Evaluation of bleomycin-induced skin sclerosis in nude mice. Arch Dermatol Res. 2004;295(10):453-456.
[15] Onda M, Bruland ØS, Pastan I. TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma. Clin Orthop Relat Res. 2005;(430):142-148.
[16] Futakuchi M, Singh RK. Animal model for mammary tumor growth in the bone microenvironment. Breast Cancer. 2013; 20(3):195-203.
[17] Kao HW, Lin YY, Chen CC, et al. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model. Bioorg Med Chem Lett. 2013;23(11):3180-3185.
[18] Kao HW, Lin YY, Chen CC, et al. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model. Nanotechnology. 2014;25(29):295102.
[19] 周光新,赵建宁.骨肉瘤动物模型构建的实验学特点[J].中国组织工程研究与临床康复,2008,12(37):7374-7377.
[20] 祝文涛,袁林,郭风劲,等.不同转移潜能MG63骨肉瘤细胞亚株裸鼠肺转移模型的建立[J].华中科技大学学报:医学版,2008,37(4): 532-534.
[21] 张岩,姜侃,冯尔宥,等.高低不同分化特性人成骨肉瘤MG-63克隆细胞株的建立[J].中国矫形外科杂志,2005,13(13):1007-1009.
|